Gene · 23308
Papers2,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention. | medRxiv | 2024 | 38766010 | PubTator, text mining | PubMed |
| A ferroptosis-related signature predicts the clinical diagnosis and prognosis, and associates with the immune microenvironment of lung cancer. | Discov Oncol | 2024 | 38743344 | PubTator, text mining | PubMed |
| Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model. | Eur J Pharm Biopharm | 2024 | 38697488 | PubTator, text mining | PubMed |
| Lipid droplets-related Perilipin-3: potential immune checkpoint and oncogene in oral squamous cell carcinoma. | Cancer Immunol Immunother | 2024 | 38554152 | PubTator, text mining | PubMed |
| ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype. | J Exp Med | 2024 | 38517331 | PubTator, text mining | PubMed |
| Immunoregulatory molecule expression on extracellular microvesicles in people living with HIV. | Front Immunol | 2024 | 38500878 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes. | Chem Biol Interact | 2024 | 38460933 | PubTator, text mining | PubMed |
| Inducing expression of ICOS-L by oncolytic adenovirus to enhance tumor-specific bi-specific antibody efficacy. | J Transl Med | 2024 | 38454393 | PubTator, text mining | PubMed |
| Immunomodulatory effects of iTr35 cell subpopulation and its research progress. | Clin Exp Med | 2024 | 38386086 | PubTator, text mining | PubMed |
| Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer. | J Immunother Cancer | 2024 | 38302415 | PubTator, text mining | PubMed |
| The Role of the CD28 Family Receptors in T-Cell Immunomodulation. | Int J Mol Sci | 2024 | 38279272 | PubTator, text mining | PubMed |
| Small Molecule Immunomodulators as Next-Generation Therapeutics for Glioblastoma. | Cancers (Basel) | 2024 | 38275876 | PubTator, text mining | PubMed |
| Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches. | J Pers Med | 2024 | 38248769 | PubTator, text mining | PubMed |
| Key inflammatory markers in bronchoalveolar lavage predict bronchiectasis progression in young children with CF. | J Cyst Fibros | 2024 | 38246828 | PubTator, text mining | PubMed |
| Immunological subtyping of salivary gland cancer identifies histological origin-specific tumor immune microenvironment. | NPJ Precis Oncol | 2024 | 38245623 | PubTator, text mining | PubMed |
| PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer. | Sci Rep | 2024 | 38245572 | PubTator, text mining | PubMed |
| Genomic and transcriptomic profiling of hepatocellular carcinoma reveals a rare molecular subtype. | Discov Oncol | 2024 | 38228856 | PubTator, text mining | PubMed |
| Single-Cell Sequencing Combined with Transcriptome Sequencing Constructs a Predictive Model of Key Genes in Multiple Sclerosis and Explores Molecular Mechanisms Related to Cellular Communication. | J Inflamm Res | 2024 | 38226354 | PubTator, text mining | PubMed |
| Integrated Bulk and Single-cell RNA Sequencing Data Constructs and Validates a Prognostic Model for Non-small Cell Lung Cancer. | J Cancer | 2024 | 38213729 | PubTator, text mining | PubMed |
| Integrated Multi-omics Analyses Identify CDCA5 as a Novel Biomarker Associated with Alternative Splicing, Tumor Microenvironment, and Cell Proliferation in Colon Cancer Via Pan-cancer Analysis. | J Cancer | 2024 | 38213717 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23308/papers?page=7